Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/10373
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPradana, Cindy M.-
dc.contributor.authorParti, Dita D.-
dc.contributor.authorSakinah, Elly N.-
dc.date.accessioned2025-06-04T04:45:12Z-
dc.date.available2025-06-04T04:45:12Z-
dc.date.issued2023-10-
dc.identifier.citationResearch Articleen_US
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/10373-
dc.description.abstractObjective: To determine the relationship between COVID-19 infection and preeclampsia in pregnant women at RSD dr. Soebandi Jember. Methods: This study used cross-sctional study with simple random sampling. The data is secondary data from medical records of 118 pregnant women who checked their pregnancies from March 2020 to December 2021 at RSD dr. Soebandi Jember and analyzed with chi-square test and logistic regression test. Results: Multivariate analysis showed that there were a relationship between COVID-19 infection with preeclampsia. COVID-19 is the most risky variable with an OR of 4.045 (95% CI 1.595 – 10.259). This condition happens because COVID-19 infection triggers down-regulation of RAS which make the failure of spiral artery remodelling and preeclampsia. Conclusion: There is a relationship between COVID-19 infection and the incidence of preeclampsia in RSD dr. Soebandi Jember.en_US
dc.language.isoen_USen_US
dc.publisherIndones J Obstet Gynecolen_US
dc.subjectCOVID-19en_US
dc.subjectpreeclampsiaen_US
dc.subjectrenin-angiotensin system (RAS)en_US
dc.subjectSARS-CoV-2en_US
dc.titleCOVID-19 Infection and the Preeclampsia in Pregnant Womenen_US
dc.typeArticleen_US
Appears in Collections:Volume 11 No 4 2023

Files in This Item:
File Description SizeFormat 
7.pdf85.59 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.